General MedicationsINJECTIONGeneric
VALPROATE SODIUM
VALPROATE SODIUM
Standard Dose
EQ 100MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview VALPROATE SODIUM is listed in Drugs@FDA under application 208120 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient VALPROATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 100MG BASE/ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2021-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview VALPROATE SODIUM is listed in Drugs@FDA under application 208120 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VALPROATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 100MG BASE/ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2021-12-22 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.